Absci Corporation
Absci Corporation (ABSI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ABSI · as of Jun 8, 2026
Key Statistics
Explore Absci Corporation Data
absi stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 75.0%
The ABSI analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $8.28, representing +26.55% upside from the current price of $6.54.
Competitors & Peers
absi competitorsABSI
CRVS
ERAS
GOSS
MGTX
MLTXStock Performance
Full HistoryAbout Absci Corporation
Absci Corporation a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integ…
what is absci corporation · absi stock overview · absci corporation company profile · who is absci corporation ceo · absi NASDAQ · absci corporation headquarters · absci corporation business segments
About Stock Overview & Key Data
Absci Corporation (ABSI) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 22, 2021. As of the latest trading session, ABSI stock price is $6.54, with a market capitalization of $1.0B. The stock has returned +115.49% over the past 12 months and +83.38% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Absci Corporation stock is Buy, with an average 12-month price target of $8.28. In fiscal year 2025, Absci Corporation reported revenue of $2.8M and net income of -$115.2M. For detailed data — including Absci Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Absci Corporation (ABSI) stock price is $6.54. The stock is traded on NASDAQ under the ticker symbol ABSI. The 52-week range is $2.24 – $7.34.